Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Repare Therapeutics
Biotech
Roche axes Repare's oncology drug days after starting study
Days after triggering a $40 million payment, Roche told Repare it is ending the deal after a review of its pipeline and “evolving external factors.”
Nick Paul Taylor
Feb 13, 2024 5:51am
Roche pays Repare $125M to join Big Pharma peers in cancer race
Jun 2, 2022 8:27am
After Repare IPO success, Amplitude closes CA$200M fund
Jun 17, 2021 5:00am
Forma, Repare snag nearly $500M collectively in upsized IPOs
Jun 19, 2020 10:10am
Legend's $350M offering as Repare, Forma get in on the action
Jun 1, 2020 8:20am
BMS jumps into synthetic lethality with $65M Repare deal
May 28, 2020 10:24am